In vitro RNA binding of the hepatitis A virus proteinase 3C (HAV 3Cpro) to secondary structure elements within the 5' terminus of the HAV genome
- PMID: 9056766
- PMCID: PMC1369481
In vitro RNA binding of the hepatitis A virus proteinase 3C (HAV 3Cpro) to secondary structure elements within the 5' terminus of the HAV genome
Abstract
The secondary structure elements at the 5' nontranslated region (NTR) of the picornaviral RNAs can be divided functionally into two domains, one of which directs cap-independent translation, whereas the other is essential for viral RNA replication. For the latter, the formation of an RNA replication complex that involves particularly viral proteinase-containing polypeptides and cellular proteins has been shown (Andino R, Rieckhof GE, Achacoso PL, Baltimore D, 1993, EMBO J 12:3587-3598; Xiang W et al., 1995, RNA 1:892-904). To initiate studies on the formation of the hepatitis A virus (HAV) RNA replication complex, binding of the HAV proteinase 3Cpro and 3CD to secondary structure elements at the 5' and 3' NTR of the HAV RNA was investigated. Using mobility shift assay, UV crosslinking/ label transfer, and northwestern analysis, we show that both the HAV 3Cpro and the proteolytically inactive mutant bind to in vitro synthesized transcripts, suggesting that the RNA-binding site of the enzyme is separated spatially from its catalytic center. Weak interactions with HAV 3Cpro were found for individual secondary structure elements comprising less than 100 nt. RNA-binding specificity was unambiguous for transcripts comprising at least two stem-loops along with the polypyrimidine tract. Furthermore, competition experiments suggest that the 5' terminus of the HAV genome contains multiple binding sites for HAV 3Cpro. In contrast to poliovirus, binding capacity of HAV 3CD to RNA of the 5' NTR was not improved as compared to 3C. The data imply that, during the viral life cycle, HAV 3Cpro might serve replicative function(s) in addition to proteolysis of the viral polyprotein.
Similar articles
-
Mapping of protein domains of hepatitis A virus 3AB essential for interaction with 3CD and viral RNA.Virology. 1999 Nov 25;264(2):410-21. doi: 10.1006/viro.1999.0017. Virology. 1999. PMID: 10562502
-
Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.Virology. 1995 Oct 20;213(1):213-22. doi: 10.1006/viro.1995.1561. Virology. 1995. PMID: 7483265
-
Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV.Virology. 1999 Dec 5;265(1):153-63. doi: 10.1006/viro.1999.9968. Virology. 1999. PMID: 10603326
-
The structure-function relationship of the enterovirus 3'-UTR.Virus Res. 2009 Feb;139(2):209-16. doi: 10.1016/j.virusres.2008.07.014. Epub 2008 Aug 30. Virus Res. 2009. PMID: 18706945 Review.
-
Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells.Viruses. 2016 Mar 17;8(3):82. doi: 10.3390/v8030082. Viruses. 2016. PMID: 26999188 Free PMC article. Review.
Cited by
-
Expression and Purification of His-Tagged Variants of Human Hepatitis A Virus 3C Protease.Protein Pept Lett. 2024;31(4):305-311. doi: 10.2174/0109298665293548240327082821. Protein Pept Lett. 2024. PMID: 38644721
-
Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases.RNA. 1998 Feb;4(2):215-25. RNA. 1998. PMID: 9570321 Free PMC article.
-
Hepatitis A virus proteinase 3C binding to viral RNA: correlation with substrate binding and enzyme dimerization.Biochem J. 2005 Jan 15;385(Pt 2):363-70. doi: 10.1042/BJ20041153. Biochem J. 2005. PMID: 15361063 Free PMC article.
-
Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C.RNA. 2002 Feb;8(2):188-201. doi: 10.1017/s1355838202012785. RNA. 2002. PMID: 11911365 Free PMC article.
-
The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases.Mol Aspects Med. 2022 Dec;88:101143. doi: 10.1016/j.mam.2022.101143. Epub 2022 Sep 21. Mol Aspects Med. 2022. PMID: 36152458 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous